The Carlyle Group
Carlyle is one of the world’s largest and most diversified global investment firms, with $276 billion of assets under management across 3 business segments and 415 investment vehicles. The firm’s mission is to drive long-term value for investors, companies, shareholders, people, communities, and employees.
Merck Global Health Innovation Fund (GHI)
Merck GHI has $500M under management and provides growth capital to emerging healthcare technology companies worldwide. With a vision that data will be the currency in healthcare, Merck GHI invests in platform companies with proven technologies or business models, where Merck’s expertise and perspectives can accelerate revenue growth and enhance value creation.
The venture capital arm of Pfizer Inc. was founded in 2004 and invests for return in areas of current or future strategic interest to Pfizer. The firm seeks to remain at the forefront of life sciences advances by identifying and investing in emerging companies that are developing transformative medicines and technologies.
Since 2004, Amgen Ventures has invested in emerging companies to advance medicines and technologies that support Amgen’s mission to treat patients with serious illnesses.
McKesson Ventures helps entrepreneurs in the healthcare technology and services space build and scale businesses that tackle some of the toughest challenges in healthcare. The firm looks for partnerships with visionary leaders who have bold ideas.
Intermountain Ventures invests in companies that are fundamentally transforming healthcare by improving quality, safety, and accessibility.
Northpond Ventures builds and supports breakthrough science- and technology-driven businesses to create a marked impact on humanity.
Population Health Partners
Population Health Partners focuses on innovative therapeutics with the potential to transform health outcomes. The firm brings together investment capital with industry-leading capabilities and technology, delivering unprecedented product development efficiency and disruptive business models.
Perceptive Advisors focuses on supporting progress in the life sciences industry, by identifying opportunities and directing financial resources toward the most promising technologies in modern healthcare.
Carrick provides capital, along with operational and investment expertise, to help entrepreneurs and their companies succeed. The firm identifies transformational industry sectors and selects companies that can best capitalize on market opportunities.